IIB 

115TH CONGRESS 

2D SESSION H. R. 4284 

IN THE SENATE OF THE UNITED STATES 

JUNE 13, 2018 

Received; read twice and referred to the Committee on Health, Education, 

Labor, and Pensions 

AN ACT 

To establish a substance use disorder information dashboard 

within the Department of Health and Human Services, 

and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


lotter on DSKBCFDHB2PROD with BILLS
2 

HR 4284 RFS

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Indexing Narcotics, 

3 Fentanyl, and Opioids Act of 2018’’ or the ‘‘INFO Act’’. 

4 SEC. 2. ESTABLISHMENT OF SUBSTANCE USE DISORDER IN5 FORMATION DASHBOARD. 

6 Title XVII of the Public Health Service Act (42 

7 U.S.C. 300u et seq.) is amended by adding at the end 

8 the following new section: 

9 ‘‘SEC. 1711. ESTABLISHMENT OF SUBSTANCE USE DIS10 ORDER INFORMATION DASHBOARD. 

11 ‘‘(a) IN GENERAL.—Not later than 6 months after 

12 the date of the enactment of this section, the Secretary 

13 of Health and Human Services shall, in consultation with 

14 the Director of National Drug Control Policy, establish 

15 and periodically update a public information dashboard 

16 that— 

17 ‘‘(1) coordinates information on programs with18 in the Department of Health and Human Services 

19 related to the reduction of opioid abuse and other 

20 substance use disorders; 

21 ‘‘(2) provides access to publicly available data 

22 from other Federal agencies; State, local, and Tribal 

23 governments; nonprofit organizations; law enforce24 ment; medical experts; public health educators; and 

25 research institutions regarding prevention, treatVerDate Sep 11 2014 00:06 Jun 14, 2018 Jkt 079200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H4284.RFS H4284

lotter on DSKBCFDHB2PROD with BILLS
3 

HR 4284 RFS

1 ment, recovery, and other services for opioid use dis2 order and other substance use disorders; 

3 ‘‘(3) provides comparable data on substance use 

4 disorder prevention and treatment strategies in dif5 ferent regions and population of the United States; 

6 ‘‘(4) provides recommendations for health care 

7 providers on alternatives to controlled substances for 

8 pain management, including approaches studied by 

9 the National Institutes of Health Pain Consortium 

10 and the National Center for Complimentary and In11 tegrative Health; and 

12 ‘‘(5) provides guidelines and best practices for 

13 health care providers regarding treatment of sub14 stance use disorders. 

15 ‘‘(b) CONTROLLED SUBSTANCE DEFINED.—In this 

16 section, the term ‘controlled substance’ has the meaning 

17 given that term in section 102 of the Controlled Sub18 stances Act (21 U.S.C. 802).’’. 

19 SEC. 3. INTERAGENCY SUBSTANCE USE DISORDER COORDI20 NATING COMMITTEE. 

21 (a) ESTABLISHMENT.—Not later than 3 months after 

22 the date of the enactment of this Act, the Secretary of 

23 Health and Human Services (in this section referred to 

24 as the ‘‘Secretary’’) shall, in consultation with the Direc25 tor of National Drug Control Policy, establish a comVerDate Sep 11 2014 00:06 Jun 14, 2018 Jkt 079200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\H4284.RFS H4284

lotter on DSKBCFDHB2PROD with BILLS
4 

HR 4284 RFS

1 mittee, to be known as the Interagency Substance Use 

2 Disorder Coordinating Committee (in this section referred 

3 to as the ‘‘Committee’’), to coordinate all efforts within 

4 the Department of Health and Human Services con5 cerning substance use disorder. 

6 (b) MEMBERSHIP.— 

7 (1) FEDERAL MEMBERS.—The following indi8 viduals shall be the Federal members of the Com9 mittee: 

10 (A) The Secretary, who shall service as the 

11 Chair of the Committee. 

12 (B) The Attorney General of the United 

13 States. 

14 (C) The Secretary of Labor. 

15 (D) The Secretary of Housing and Urban 

16 Development. 

17 (E) The Secretary of Education. 

18 (F) The Secretary of Veterans Affairs. 

19 (G) The Commissioner of Social Security. 

20 (H) The Assistant Secretary for Mental 

21 Health and Substance Use. 

22 (I) The Director of the Centers for Disease 

23 Control and Prevention. 

24 (J) The Director of the National Institutes 

25 of Health and the Directors of such national reVerDate Sep 11 2014 00:06 Jun 14, 2018 Jkt 079200 PO 00000 Frm 00004 Fmt 6652 Sfmt 6201 E:\BILLS\H4284.RFS H4284

lotter on DSKBCFDHB2PROD with BILLS
5 

HR 4284 RFS

1 search institutes of the National Institutes of 

2 Health as the Secretary determines appropriate. 

3 (K) The Administrator of the Centers for 

4 Medicare & Medicaid Services. 

5 (L) The Director of National Drug Control 

6 Policy. 

7 (M) Representatives of other Federal agen8 cies that serve individuals with substance use 

9 disorder. 

10 (2) NON-FEDERAL MEMBERS.—The Committee 

11 shall include a minimum of 17 non-Federal members 

12 appointed by the Secretary, of which— 

13 (A) at least two such members shall be an 

14 individual who has received treatment for a di15 agnosis of an opioid use disorder; 

16 (B) at least two such members shall be an 

17 individual who has received treatment for a di18 agnosis of a substance use disorder other than 

19 an opioid use disorder; 

20 (C) at least two such members shall be a 

21 State Alcohol and Substance Abuse Director; 

22 (D) at least two such members shall be a 

23 representative of a leading research, advocacy, 

24 or service organization for adults with sub25 stance use disorder; 


lotter on DSKBCFDHB2PROD with BILLS
6 

HR 4284 RFS

1 (E) at least two such members shall— 

2 (i) be a physician, licensed mental 

3 health professional, advance practice reg4 istered nurse, or physician assistant; and 

5 (ii) have experience in treating indi6 viduals with opioid use disorder or other 

7 substance use disorders; 

8 (F) at least one such member shall be a 

9 substance use disorder treatment professional 

10 who is employed with an opioid treatment pro11 gram; 

12 (G) at least one such member shall be a 

13 substance use disorder treatment professional 

14 who has research or clinical experience in work15 ing with racial and ethnic minority populations; 

16 (H) at least one such member shall be a 

17 substance use disorder treatment professional 

18 who has research or clinical mental health expe19 rience in working with medically underserved 

20 populations; 

21 (I) at least one such member shall be a 

22 State-certified substance use disorder peer sup23 port specialist; 

24 (J) at least one such member shall be a 

25 drug court judge or a judge with experience in 


lotter on DSKBCFDHB2PROD with BILLS
7 

HR 4284 RFS

1 adjudicating cases related to substance use dis2 order; 

3 (K) at least one such member shall be a 

4 law enforcement officer or correctional officer 

5 with extensive experience in interacting with 

6 adults with a substance use disorder; and 

7 (L) at least one such member shall be an 

8 individual with experience providing services for 

9 homeless individuals and working with adults 

10 with a substance use disorder. 

11 (c) TERMS.— 

12 (1) IN GENERAL.—A member of the Committee 

13 appointed under subsection (b)(2) shall be appointed 

14 for a term of 3 years and may be reappointed for 

15 one or more 3-year terms. 

16 (2) VACANCIES.—A vacancy on the Committee 

17 shall be filled in the same manner in which the origi18 nal appointment was made. Any individual appointed 

19 to fill a vacancy for an unexpired term shall be ap20 pointed for the remainder of such term and may 

21 serve after the expiration of such term until a suc22 cessor has been appointed. 

23 (d) MEETINGS.—The Committee shall meet not fewer 

24 than two times each year. 

25 (e) DUTIES.—The Committee shall— 


lotter on DSKBCFDHB2PROD with BILLS
8 

HR 4284 RFS

1 (1) monitor opioid use disorder and other sub2 stance use disorder research, services, and support 

3 and prevention activities across all relevant Federal 

4 agencies, including coordination of Federal activities 

5 with respect to opioid use disorder and other sub6 stance use disorders; 

7 (2) identify and provide to the Secretary rec8 ommendations for improving Federal grants and 

9 programs for the prevention and treatment of, and 

10 recovery from, opioid use disorder and other sub11 stance use disorders; 

12 (3) review substance use disorder prevention 

13 and treatment strategies in different regions and 

14 populations in the United States and evaluate the 

15 extent to which Federal substance use disorder pre16 vention and treatment strategies are aligned with 

17 State and local substance use disorder prevention 

18 and treatment strategies; 

19 (4) make recommendations to the Secretary re20 garding any appropriate changes with respect to the 

21 activities and strategies described in paragraphs (1) 

22 through (3); 

23 (5) make recommendations to the Secretary re24 garding public participation in decisions relating to 

25 opioid use disorder and other substance use disVerDate Sep 11 2014 00:06 Jun 14, 2018 Jkt 079200 PO 00000 Frm 00008 Fmt 6652 Sfmt 6201 E:\BILLS\H4284.RFS H4284

lotter on DSKBCFDHB2PROD with BILLS
9 

HR 4284 RFS

1 orders and the process by which public feedback can 

2 be better integrated into such decisions; and 

3 (6) make recommendations to ensure that 

4 opioid use disorder and other substance use disorder 

5 research, services, and support and prevention activi6 ties of the Department of Health and Human Serv7 ices and other Federal agencies are not unneces8 sarily duplicative. 

9 (f) ANNUAL REPORT.— 

10 (1) IN GENERAL.—Not later than 1 year after 

11 the date of the enactment of this Act, and annually 

12 thereafter for the life of the Committee, the Com13 mittee shall publish on the public information dash14 board established under section 2(a) a report sum15 marizing the activities carried out by the Committee 

16 pursuant to subsection (e), including any findings 

17 resulting from such activities. 

18 (2) RECOMMENDATION FOR COMMITTEE EX19 TENSION.—After the publication of the second re20 port of the Committee under paragraph (1), the Sec21 retary shall submit to Congress a recommendation 

22 on whether or not the operations of the Committee 

23 should continue after the termination date described 

24 in subsection (i). 


lotter on DSKBCFDHB2PROD with BILLS
10 

HR 4284 RFS

1 (g) WORKING GROUPS.—The Committee may estab2 lish working groups for purposes of carrying out the duties 

3 described in subsection (e). Any such working group shall 

4 be composed of members of the Committee (or the des5 ignees of such members) and may hold such meetings as 

6 are necessary to enable the working group to carry out 

7 the duties delegated to the working group. 

8 (h) FEDERAL ADVISORY COMMITTEE ACT.—The 

9 Federal Advisory Committee Act (5 U.S.C. App.) shall 

10 apply to the Committee only to the extent that the provi11 sions of such Act do not conflict with the requirements 

12 of this section. 

13 (i) SUNSET.—The Committee shall terminate on the 

14 date that is 6 years after the date on which the Committee 

15 is established under subsection (a). 

Passed the House of Representatives June 12, 2018. 

Attest: KAREN L. HAAS, 

Clerk. 


lotter on DSKBCFDHB2PROD with BILLS